Delivery Order SPE2DB20D1050-SPE2DB24FH74E

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The single-award Indefinite Delivery Contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, primarily Cosentyx 150mg/ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $72,445.21, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The firm-fixed-price delivery order, valued at $13,697.55, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Cosentyx medication, a prescription drug treatment, in the amount of $3,263.65. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Cosentyx pharmaceutical products to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,800.87 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of Cosentyx, a specialty biologic medication, over a 2-year period ending in June 2024. The firm-fixed-price, $3,043.90 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, through which the company provides a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,504.50 firm fixed price delivery order is for the supply of Cosentyx 300 mg dose-2 prefilled syringes. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,974.84 delivery order is for the supply of Cosentyx, a prescription medication used to treat certain immune system disorders. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between Amerisourcebergen and DLA, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,043.90 Firm Fixed Price Delivery Order is for the supply of the drug product Cosentyx (300 mg dose, 2 pens per milliliter) to the DLA. The contract has a period of performance through June 12, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $6,293.00 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the pharmaceutical product Cosentyx SNRDY 300MG DOSE-2PENML. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB24FH74E
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Cosentyx medical injections to the Defense Logistics Agency (DLA). The award, valued at $2,659.66, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/19/24, 9:29 AM